PURPLE INNOVATION, INC. PRPL
2.47
(0.07)
(2.76%)
as of 25 Sep
- Market cap
- $11.1M
- P/E
- 0.0×
Follow PRPL
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.09 | 0.16 | 0.16 | 0.22 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
60.08 | 23.98 | (12.88) | (104.44) | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.58 | 0.40 | 0.38 | 0.41 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(83.58) | (23.44) | (5.26) | (8.83) | |
EV/FCF |
(24.69) | (11.43) | (4.23) | (6.60) | |
Quick Ratio |
0.23 | 0.49 | 0.65 | 0.59 | |
Current Ratio |
0.52 | 1.24 | 1.35 | 1.40 | |
Net Debt/EBITDA |
491.50 | (7.59) | 39.17 | (30.04) | |
Debt/Assets |
48.02% | 43.83% | 37.57% | 34.06% | |
Debt/Equity |
(1.99) | (1.98) | (3.75) | (3.82) | |
Asset Turnover |
1.60 | 1.63 | 1.55 | 1.50 | |
Operating CF/Net income |
(0.20) | (0.10) | 1.81 | 0.08 | |
Capex/Depreciation |
(0.52) | (0.46) | (0.50) | (0.09) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
2.53% | 2.56% | 1.85% | 1.99% | |
Selling, General and Administrative Expense of Revenue |
46.99% | 51.80% | 38.19% | 46.58% | |
Intangible Assets out of Total Assets |
0.02 | 0.02 | 0.02 | 0.02 | |
Share Based Compensation of Revenue |
(0.38%) | 0.16% | 0.33% | 0.35% | |
Graham Net Nets |
(5.50) | (3.02) | (2.53) | (1.91) | |
Graham Number |
60.88 | 67.27 | 43.05 | 43.04 | |
Earnings Yield |
(125.87%) | (87.72%) | (69.44%) | (56.75%) | |
Free Cash Flow Yield |
(27.27%) | (22.24%) | (56.37%) | (28.17%) | |
Revenue per Share |
22.58 | 22.08 | 32.54 | 27.43 | |
Operating CF per Share |
0.15 | 0.69 | (1.34) | (0.22) | |
Capex per Share |
(0.53) | (0.47) | (0.51) | (0.21) | |
Free Cash Flow per Share |
(0.38) | 0.22 | (1.85) | (0.44) | |
Cash per Share |
5.35 | 5.76 | 5.63 | 7.47 | |
Shareholders Equity per Share |
(14.66) | (13.87) | (6.86) | (6.21) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(14.66) | (13.87) | (6.86) | (6.21) | |
Free Cash Flow |
(1.65) | 0.96 | (8.01) | (1.89) | |
Working Capital |
(105.24) | 22.36 | 35.20 | 39.31 | |
Capital Expenditures |
(2.30) | (2.03) | (2.21) | (0.92) | |
Net Current Asset Value |
(213.82) | (216.55) | (189.21) | (192.62) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.01 | |
Net Profit Margin |
(3.29%) | (31.90%) | (2.28%) | (9.87%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
23.66 | 22.77 | 37.16 | 27.44 | |
Average Payables |
33.57 | 37.17 | 40.48 | 33.03 | |
Average Inventory |
58.15 | 59.13 | 58.29 | 62.83 | |
Average Assets |
284.14 | 282.88 | 302.05 | 305.70 | |
Average Common Equity |
(39.69) | (29.40) | (4.73) | 0.55 |
Columns are period end dates